C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 38/12 (2006.01) A61K 38/15 (2006.01) C07H 21/02 (2006.01) C07H 21/04 (2006.01)
Patent
CA 2648160
Methods for diagnosis, prognosis, and treatment of cancer based on the methylation status of the ER-.alpha. gene promoter are disclosed. Methylation of the ER-.alpha. gene promoter is indicative of cancer and unfavorable prognosis. The cancer can be treated with a demethylation agent.
L'invention concerne des procédés de diagnostic, de pronostic, et de traitement du cancer basés sur l'état de méthylation du promoteur du gène ER-.alpha.. La méthylation du promoteur du gène ER-.alpha. indique le cancer ou un pronostic défavorable. Le cancer peut être traité avec un agent de déméthylation.
John Wayne Cancer Institute
Oyen Wiggs Green & Mutala Llp
LandOfFree
Methylation of estrogen receptor alpha and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methylation of estrogen receptor alpha and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methylation of estrogen receptor alpha and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1426253